Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole for steroid-sensitive nephrotic syndrome in children
NL-OMON26305Recruiting
- Sponsor
- Amsterdam UMC
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in idiopathic steroid-sensitive nephrotic syndrome (SSNS) comparing Levamisole with Placebo (2 arms). Primary endpoint: Time to relapse. Started May 2007; status: recruiting.
02
Drugs
levamisole
03
Conditions
idiopathic steroid-sensitive nephrotic syndrome (SSNS)
Beyond the preview
Go deeper on NL-OMON26305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26305.